genomics

Washington University in St. Louis graduate student Andrea Karl found herself thrust into the national spotlight this month at the St. Louis GO! Marathon when an imposter at the finish line denied Karl her first-place accolades. She got to recreate the finish at Busch Stadium. Karl is working towards a PhD in molecular genetics and genomics in the Division of Biology & Biomedical Sciences (DBBS) at the School of Medicine. DBBS is in the Graduate School of Arts & Sciences.

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at the School of Medicine including senior author Robert Schreiber, PhD, has brought the approach one step closer to reality.

Elaine R. Mardis, PhD, and Richard K. Wilson, PhD, both renowned for discoveries in the field of genomics, have been named to endowed professorships. They were installed by Chancellor Mark S. Wrighton (far left), and Larry J. Shapiro, MD, executive vice chancellor for medical affairs and dean of the School of Medicine (far right).

Elaine Mardis, co-director of The Genome Institute at Washington University School of Medicine in St. Louis, is featured in Discover magazine’s “100 Top Stories of 2013,” for her pioneering work in cancer genomics.

Soil bacteria and bacteria that cause human diseases have recently swapped at least seven antibiotic-resistance genes, researchers at Washington University School of Medicine report on Aug. 31 in Science.

Washington University is in the spotlight for its pivotal role in the Genomics Education Partnership, a collaborative effort to provide research experience in genomics to undergraduate classrooms across the country.

ElginWashington University in St. Louis is in the spotlight for its pivotal role in the Genomics Education Partnership, a collaborative effort to provide research experience in genomics to undergraduate classrooms across the country. At the helm of this mission is Sarah C.R. Elgin, Ph.D., WUSTL professor of biology and professor of education in Arts & Sciences, as well as professor of biochemistry & molecular biophysics and professor of genetics in the School of Medicine.

The next generation of consumers will be the true beneficiaries of the promise of genomics. But how will they make informed choices in a world resplendent with genomics products, including tools to predict disease and the engineered drugs to treat those diseases? The answer, says Sarah C.R. Elgin, Ph.D., WUSTL professor of biology in Arts & Sciences, is more genetics and genomics at every level of American education.

Courtesy of the National Cancer InstituteBreast cancer cells stained brown using an antibody that recognizes malignant cellsClinical studies are proving that the genetic profile of a tumor can greatly influence its response to anticancer treatments. WUSM physician Matthew Ellis is conducting research that aims to use the genetic profile of breast tumors to guide breast cancer therapy and ultimately to find new drugs for treating the disease.

Courtesy of the National Cancer InstituteBreast cancer cells stained brown using an antibody that recognizes malignant cellsClinical studies are proving that the genetic profile of a tumor can greatly influence its response to anticancer treatments. Matthew J. Ellis, M.D., Ph.D., at Washington University School of Medicine in St. Louis, is conducting research that aims to use the genetic profile of breast tumors to guide breast cancer therapy and ultimately to find new drugs for treating the disease.